StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report issued on Sunday. The firm issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Price Performance
Shares of NASDAQ:BLPH opened at $0.05 on Friday. The stock has a market cap of $623,883.00, a P/E ratio of -0.06 and a beta of 0.73. Bellerophon Therapeutics has a 1-year low of $0.03 and a 1-year high of $0.52. The firm has a fifty day moving average price of $0.06 and a 200 day moving average price of $0.06.
Bellerophon Therapeutics Company Profile
Further Reading
- Five stocks we like better than Bellerophon Therapeutics
- What is a buyback in stocks? A comprehensive guide for investors
- Uber’s Earnings Beat: Rideshare and Delivery Surge
- The Role Economic Reports Play in a Successful Investment Strategy
- Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
- Investing in Commodities: What Are They? How to Invest in Them
- Cloudflare Stock Flares Up on Solid EPS Beat and Raised Guidance
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
